1.
Study on Coagulant/Fibrinolytic Activity at Monocytic Level in Coronary Heart Disease Patients with Blood Stasis Syndrome and the Effect of Therapies of Nourishing Qi/Moving Blood of Traditional Chinese Medicine
冠心病血瘀证单核细胞凝血/纤溶活性改变及药物干预研究
2.
The Change of Coagulation and Fibrinolysis Activity in Bleomycin-induced Lung Fibrosis in Rat;
博莱霉素致肺纤维化大鼠凝血及纤溶活性变化的研究
3.
The Abnormality of Coagulation and Fibrinolysis on Patient with Transient Ischemic Attacks;
短暂脑缺血发作患者急性期凝血—纤溶活性的异常
4.
Study of the Relativity between Thrombin-activatable Fibrinolysis Inhibtor and Stroke
血浆凝血酶激活的纤溶抑制物与脑卒中的相关性研究
5.
The Relationship between Thrombin-Activatable Fibrinolysis Inhibitor and Risk of Stroke
血浆凝血酶激活的纤溶抑制物与脑卒中的相关性
6.
A Study of Relation between Thrombin Activatable Fi Brinolysis Inhibition and Coronary Heart Disease.;
凝血酶激活的纤溶抑制物与冠心病的相关性研究
7.
Genetic polymorphism of thrombin-activatable fibrinolysis inhibitor(TAFI) associated with type 2 diabetes mellitus
凝血酶激活的纤溶抑制物编码区基因多态性与2型糖尿病的关系
8.
Thrombin is an enzyme that catalyzes the conversion of the soluble plasma protein fibrinogen to the insoluble protein fibrin.
凝血酶能催化可溶性血浆纤维蛋白转化为不溶性的纤维蛋白。
9.
Effects of Thrombin-activable Fibrinolysis Inhibitor and Hirudin on Fibrinolysis;
凝血酶激活的纤溶抑制剂与水蛭素对纤溶的影响
10.
Study on the Levels of Thrombin Activable Fibrinolysis Inhibitor Active(TAFIa) in the Patients with Hemophilia
血友病患者凝血酶激活的纤维蛋白溶解抑制物活性(TAFIa)的检测及其临床意义
11.
Assessment of Coagulation, Fibrinolysis and Platelet Activation in Coronary Sinus Blood Induced by Cutting Balloon Angioplasty for Patiens with Coronary Heart Disease;
冠状动脉腔内切割球囊血管成形术对冠心病患者凝血、纤溶指标及血小板活性的影响
12.
Studies on the Thrombin Activatable Fibrinolysis Inhibitor of Coronary Atherosclerotic Heart Disease;
冠心病患者凝血酶激活的纤溶抑制物研究
13.
Correlativity between blood-stasis syndrome in cardiopathy and activity of f ibrinolytic system
心病血瘀证与纤溶系统活性的相关性
14.
Value of diagnostic indices of fibrinolysis in diffuse intravascular coagulation
纤溶指标对弥漫性血管内凝血的诊断价值
15.
Comparison of the effect of tumor necrosis factor-alpha and lippolysaccharide on the activities of coagulation and fibrinolysis in human brain microvascular endothelial cells
比较肿瘤坏死因子α和内毒素对人脑微血管内皮细胞凝血和纤溶活性的影响
16.
Clinical significance of coagulation and fibrinolysis indicators in diagnosis of DIC in obstetrics
凝血与纤溶指标在产科弥漫性血管内凝血诊断中的意义
17.
Relationship between Thrombin Activated Fibrinolysis Inhibitor in Plasma and Vascular Complication in Type 2 Diabetes;
血浆凝血酶激活的纤溶抑制物与2型糖尿病血管并发症的关系
18.
Analysis of the Relationship Between Thrombin Activatable Fibrinolysis Inhibitor and Fibrinogen in Patients with Coronary Atherosclerotic Heart Disease
冠心病患者凝血酶激活的纤溶抑制物与纤维蛋白原关系分析